Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants

NCT05285735 is registered in ClinicalTrials.gov with Amivas Inc. as lead sponsor.

NCT NCT05285735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05285735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Lead sponsor
Amivas Inc.
Phase
Observational
Overall status
Recruiting
Start date
June 8, 2022
Completion date
July 1, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, pregnancy